Barry Siegel

Medicine & Life Sciences

1. Positron-Emission Tomography 100%
2. Fluorodeoxyglucose F18 54%
3. Neoplasms 32%
4. Uterine Cervical Neoplasms 29%
5. Radionuclide Imaging 28%
6. Deoxyglucose 22%
7. Positron Emission Tomography Computed Tomography 21%
8. Neoplasm Metastasis 20%
9. Non-Small Cell Lung Carcinoma 17%
10. Lymph Nodes 16%
11. Tomography 15%
12. Survival 15%
13. Registries 14%
14. Radiopharmaceuticals 14%
15. Carcinoma 13%
16. Radiotherapy 12%
17. Breast Neoplasms 12%
18. Tumor Burden 11%
19. Radiology 11%
20. carbon-11 acetate 11%
21. Colorectal Neoplasms 10%
22. Recurrence 10%
23. Therapeutics 10%
24. Thyroid Neoplasms 10%
25. Blood Platelets 9%
26. Radioisotopes 9%
27. Pulmonary Embolism 9%
28. Indium-111 9%
29. Electrons 8%
30. Medicare 8%
31. Perfusion 8%
32. Prostatic Neoplasms 8%
33. Liver 8%
34. Cervix Uteri 8%
35. Brain 7%
36. Infarction 7%
37. Thrombosis 7%
38. Fluorides 7%
39. Bone and Bones 6%
40. Glucose 6%
41. Lung 6%
42. Estrogen Receptors 6%
43. Estradiol 6%
44. fluciclovine F-18 6%
45. Squamous Cell Carcinoma of Head and Neck 6%
46. Tumor Hypoxia 6%
47. Technetium 6%
48. Cetuximab 6%
49. Prospective Studies 5%
50. Magnetic Resonance Imaging 5%